EU Horizon
Korte Vijverberg 5, 's-Gravenhage, Zuid-Holland, 2513AB, The Netherlands
Overview
Horizon Europe is an European Union's research & innovation framework programme for 2021-2027.
- Total investments
- 4
- Lead investments
- 3
- Investments · 12mo
- 1
- Active investors
- 0
Investment portfolio
- Notpla
Led · Grant · Jan 2026
Notpla is a materials-innovation company that creates natural, seaweed-derived packaging and coatings intended to disappear harmlessly after use. The firm is now spearheading a three-year consortium to design a market-ready coffee cup featuring a fully natural, plastic-free coating that can be home-composted. Backed by a €4 million Horizon Europe grant, the project will investigate new coating chemistries, scalable production methods and real-world performance testing that comply with EU waste-management regulations. Notpla’s existing solutions have already displaced more than 35 million plastic single-use items across food service, events and retail. By targeting the estimated 500 billion disposable cups used annually, the company seeks to unlock a major new application for its technology. Fourteen partners spanning material science, manufacturing, academia and food service will collaborate to ensure the cup performs under high-volume hospitality conditions. The non-dilutive funding strengthens Notpla’s balance sheet while expanding its IP portfolio and product roadmap. Successful execution could position Notpla as a leading supplier of plastic-free packaging to global beverage and hospitality markets.
- CroíValve
Led · Equity · Jul 2025
CroíValve is developing the DUO System, a novel transcatheter heart valve that preserves native anatomy and works in tandem with the tricuspid valve to restore function while avoiding contact with critical right-heart structures. The DUO Adapt System features an adaptive coaptation valve designed to fill larger and complex leaks and has shown early clinical use treating leaks up to 35mm with significant reduction in tricuspid regurgitation. The device is investigational and not for sale in any geography. CroíValve plans to expand its TANDEM II prospective, multicenter study across additional US and EU sites to further evaluate safety and performance, building on 15 patients already treated. The company recently expanded its Series B financing and secured grant funding to support this clinical expansion, and has R&D and operations in Ireland with clinical and regulatory functions in the US.
- Melt&Marble
Led · Grant · Jul 2024
Melt&Marble is a Gothenburg-based biotech company that uses advanced microbial engineering and precision fermentation to produce fats without relying on animal or plant sources. Its technology custom-designs lipid profiles, aiming to deliver cost-competitive, locally produced ingredients that satisfy both performance and sustainability requirements. The company targets food and personal-care manufacturers, positioning its fats as functional replacements for conventional animal or tropical oils. Melt&Marble emphasizes scalability, planning to expand production capacity and launch its first commercial ingredients following its new financing. Management states that its approach can meet strict technical specifications while reducing environmental impact. Over the past year the company has secured €10 million in combined equity and non-dilutive funding, strengthening its financial footing for upcoming pilots and go-to-market efforts.
- Comptek Solutions
Participated · Series A · Aug 2023
Comptek Solutions develops surface engineering technologies for semiconductor device manufacturing, centered on Kontrox, a novel processing technology that improves chip efficiency and reduces production costs. The company was founded in June 2017 as a spin-off of the University of Turku by CTO Jouko Lång and CEO Vicente Calvo Alonso and is based in Turku, Finland. Kontrox is positioned to support rapid adoption of innovations such as 5G/6G communications, AR/VR, mobility, IoT, and quantum computing. Comptek plans to use recent funding to accelerate industrialization and implementation of its technology for next-generation optoelectronics and power electronics. Financially, the company completed an €8m Series A to fund growth and advance its technological innovation. The raise is intended to support commercialization and scale-up of the Kontrox processing technology.
Team
No current team members are available.